The relatively predominant cardiovascular pharmacologic effect of a drug with multipharmacologic effects; used especially when describing beta-blocking agents.
Chemwatch helps thousands of organisations manage chemical safety. Book a free demo to see how.
As scientists who evolve with technology we treat innovation as a way of life, a life we dedicate to improvement and advancement of Safety, Health and Environment.
